TABLE 1.
Characteristics | Alzheimer’s disease | Parkinson’s disease | References |
Affected brain regions (Autopsy findings) | Hippocampus, cortex (Frontal, occipital, and cingulate), insula. | Midbrain, basal ganglia, thalamus. | Solomon et al., 2020; von Weyhern et al., 2020; Generoso et al., 2021 |
Brain morphological and macroscopic changes | Edema, hemorrhagic lesions, hydrocephalus, atrophy and low brain mass, infarcts. | Paniz-Mondolfi et al., 2020; Reichard et al., 2020; Wichmann et al., 2020 | |
Brain regions expressing ACE2 and TMPRSS2 | Prefrontal cortex, hippocampus. | Striatum (Human brain), SNpr, SNpc (mouse brain) | Chen R. et al., 2020; Qiao et al., 2020 |
Intracellular SARS-CoV-2 | Frontal cortex | No findings report | Paniz-Mondolfi et al., 2020; Liu J. M. et al., 2021 |
Biochemical markers | Glia and microglia response, cytokine storm (increased interleukins IL-1β, IL-6, IL-8, IL-12, IL-17, IL-18). Oxidative stress in various brain regions such as BBB and neurons susceptible to cell death. | Chaudhry et al., 2020; Almutairi et al., 2021;Chiricosta et al., 2021; Frank et al., 2022 |
SNpr, substantia nigra pars reticulate; SNpc, substantia nigra pars compacta; IL, interleukin.